SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011477
Filing Date
2024-08-08
Accepted
2024-08-08 08:06:22
Documents
56
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ewtx-20240630x10q.htm   iXBRL 10-Q 1942159
2 EX-3.1 ewtx-20240630xex3d1.htm EX-3.1 69948
3 EX-31.1 ewtx-20240630xex31d1.htm EX-31.1 19403
4 EX-31.2 ewtx-20240630xex31d2.htm EX-31.2 19216
5 EX-32.1 ewtx-20240630xex32d1.htm EX-32.1 7610
6 EX-32.2 ewtx-20240630xex32d2.htm EX-32.2 7533
  Complete submission text file 0001558370-24-011477.txt   6179678

Data Files

Seq Description Document Type Size
7 EX-101.SCH ewtx-20240630.xsd EX-101.SCH 31172
8 EX-101.CAL ewtx-20240630_cal.xml EX-101.CAL 38013
9 EX-101.DEF ewtx-20240630_def.xml EX-101.DEF 121395
10 EX-101.LAB ewtx-20240630_lab.xml EX-101.LAB 314059
11 EX-101.PRE ewtx-20240630_pre.xml EX-101.PRE 225954
59 EXTRACTED XBRL INSTANCE DOCUMENT ewtx-20240630x10q_htm.xml XML 893257
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40236 | Film No.: 241186171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)